Puma Biotechnology Inc expected to post a loss of 9  cents a share - Earnings Preview

Puma Biotechnology

01/03/2022 22:40

* Puma Biotechnology Inc  PBYI.OQ   PBYI.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 3. 
    * The Los Angeles California-based  company is expected to
report 
a 10.3% decrease in revenue to $47.167 million from $52.6
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Puma Biotechnology
Inc is
for a loss of 9 cents per share. For the same quarter last year,
the company reported a loss of 38 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 3 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $6​, about 61.7% above​ its last closing
price of $2.30. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.32       -0.31      -0.90     Missed  -188.8
 Jun. 30 2021  -0.25       -0.27      -0.13     Beat    52.1
 Mar. 31 2021  0.16        0.09       0.40      Beat    359.8​
 Dec. 31 2020  -0.41       -0.31      -0.38     Missed  -21.7
 ​​Sep.        -0.41       -0.39      -0.79     Missed  -100.1
 30 2020                                                
 Jun. 30 2020  -0.34       -0.30      0.08      Beat    126.9​
 Mar. 31 2020  -0.78       -0.77      -0.43     Beat    44.3
 Dec. 31 2019  -0.48       -0.48      -0.29     Beat    40.2
 This summary was machine generated March 1 at 22:40 GMT.  All
figures in US dollars  unless otherwise stated